RAPID3 (routine assessment of patient index data 3) is a pooled index of the 3 patient-
reported American College of Rheumatology rheumatoid arthritis (RA) Core Data Set …

Objective. To compare the benefit and safety of tocilizumab to placebo in patients with
rheumatoid arthritis (RA). Methods. We searched multiple databases for published …

Objective Remission in rheumatoid arthritis (RA) is an increasingly attainable goal, but there
is no widely used definition of remission that is stringent but achievable and could be …

Background The health-related quality of life (HRQL) is an important indicator of the burden
of musculoskeletal disease. The Medical Outcome Study Short-Term 36 (SF-36) is the most …

Objective To compare 4 categories (high, moderate, and low severity, and near-remission)
of RAPID3 (Routine Assessment of Patient Index Data 3), an index without formal joint …

Objectives. To analyse the capacity of routine assessment of patient index data 3 (RAPID3),
an index of only the three patient-reported outcome (PRO) measures in the RA Core Data …

Abstract Objective To compare the Routine Assessment of Patient Index Data 3 (RAPID3) on
a Multidimensional Health Assessment Questionnaire (MDHAQ) with the Disease Activity …

Abstract Interleukin (IL)-6 is produced locally in response to an inflammatory stimulus, and is
able to induce systemic manifestations at distance from the site of inflammation. Its unique …

Objectives The aim of rheumatoid arthritis (RA) treatment is remission. As treatment should
be targeted at outcomes relevant to patients, it is important to understand how patients …

Objective To compare categories for activity/severity according to the Disease Activity Score
28‐joint count (DAS28), the Clinical Disease Activity Index (CDAI), and the Routine …